Development and Evaluation of the Kansas City Cardiomyopathy Questionnaire: a New Health Status Measure for Heart Failure
Overview
Authors
Affiliations
Objectives: To create a valid, sensitive, disease-specific health status measure for patients with congestive heart failure (CHF).
Background: Quantifying health status is becoming increasingly important for CHF. The Kansas City Cardiomyopathy Questionnaire (KCCQ) is a new, self-administered, 23-item questionnaire that quantifies physical limitations, symptoms, self-efficacy, social interference and quality of life.
Methods: To establish the performance characteristics of the KCCQ, two distinct patient cohorts were recruited: 70 stable and 59 decompensated CHF patients with ejection fractions of <40. Upon entry into the study, patients were administered the KCCQ, the Minnesota Living with Heart Failure Questionnaire and the Short Form-36 (SF-36). Questionnaires were repeated three months later.
Results: Convergent validity of each KCCQ domain was documented by comparison with available criterion standards (r = 0.46 to 0.74; p < 0.001 for all). Among those with stable CHF who remained stable by predefined criteria (n = 39), minimal changes in KCCQ domains were detected over three months of observation (mean change = 0.8 to 4.0 points, p = NS for all). In contrast, large changes in score were observed among patients whose decompensated CHF improved three months later (n = 39; mean change = 15.4 to 40.4 points, p < 0.01 for all). The sensitivity of the KCCQwas substantially greater than that of the Minnesota Living with Heart Failure and the SF-36 questionnaires.
Conclusions: The KCCQis a valid, reliable and responsive health status measure for patients with CHF and may serve as a clinically meaningful outcome in cardiovascular research, patient management and quality assessment.
Kwast S, Hoffmann J, Pokel C, Falz R, Schulze A, Schroter T Sci Rep. 2025; 15(1):8940.
PMID: 40089637 DOI: 10.1038/s41598-025-94172-1.
William S, McDonagh J, Allida S, Kasa A, Patterson C, Deek H NPJ Cardiovasc Health. 2025; 2(1):10.
PMID: 40061843 PMC: 11888987. DOI: 10.1038/s44325-025-00044-y.
Goetz I, Sutter C, Abraham T, Kanu C, Boye K, Symonds T J Patient Rep Outcomes. 2025; 9(1):23.
PMID: 39976863 PMC: 11842654. DOI: 10.1186/s41687-025-00841-0.
Tokarewicz J, Jankowiak B, Klimaszewska K, Swieczkowski M, Matlak K, Dobrzycki S J Clin Med. 2025; 14(3).
PMID: 39941398 PMC: 11818487. DOI: 10.3390/jcm14030729.
Barnard-Kelly K, Battelino T, Brosius F, Ceriello A, Cosentino F, Gavin 3rd J Cardiovasc Diabetol. 2025; 24(1):68.
PMID: 39920737 PMC: 11806799. DOI: 10.1186/s12933-024-02550-2.